These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15938386)

  • 21. Hepatitis C virus antiviral therapy in patients with cirrhosis.
    Arenas JI; Vargas HE
    Gastroenterol Clin North Am; 2004 Sep; 33(3):549-62, ix. PubMed ID: 15324943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia.
    Sievert W; Razavi H; Estes C; Thompson AJ; Zekry A; Roberts SK; Dore GJ
    J Gastroenterol Hepatol; 2014 Aug; 29 Suppl 1():1-9. PubMed ID: 25055928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study].
    Witjes CD; de Man RA; Eskens FA; Dwarkasing RS; Zondervan PE; Verhoef C; Ijzermans JN
    Ned Tijdschr Geneeskd; 2010; 154():A1747. PubMed ID: 20719013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil.
    Kikuchi L; Chagas AL; Alencar RS; Paranaguá-Vezozzo DC; Carrilho FJ
    Antivir Ther; 2013; 18(3 Pt B):445-9. PubMed ID: 23793796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral therapy for hepatitis B virus-related decompensated cirrhosis.
    Wang JY
    J Dig Dis; 2012 Nov; 13(11):555-7. PubMed ID: 23107441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis.
    Kim SS; Hwang JC; Lim SG; Ahn SJ; Cheong JY; Cho SW
    Am J Gastroenterol; 2014 Aug; 109(8):1223-33. PubMed ID: 24890440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective evaluation of the management of hepatocellular carcinoma in the elderly.
    Ozenne V; Bouattour M; Goutté N; Vullierme MP; Ripault MP; Castelnau C; Valla DC; Degos F; Farges O
    Dig Liver Dis; 2011 Dec; 43(12):1001-5. PubMed ID: 21798829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multimodal therapy for liver cirrhosis patients with advanced hepatocellular carcinoma.
    Nagai H; Matsui T; Kanayama M; Wakui N; Momiyama K; Watanabe M; Igarashi Y; Sumino Y
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):139-45. PubMed ID: 20857114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C.
    Sangro B; Gomez-Martin C; de la Mata M; Iñarrairaegui M; Garralda E; Barrera P; Riezu-Boj JI; Larrea E; Alfaro C; Sarobe P; Lasarte JJ; Pérez-Gracia JL; Melero I; Prieto J
    J Hepatol; 2013 Jul; 59(1):81-8. PubMed ID: 23466307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis.
    Testino G; Ansaldi F; Andorno E; Ravetti GL; Ferro C; De Iaco F; Icardi G; Valente U
    Hepatogastroenterology; 2002; 49(48):1636-8. PubMed ID: 12397752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cirrhosis due to hepatitis C virus].
    Trinchet JC
    Rev Prat; 2000 May; 50(10):1094-9. PubMed ID: 10905095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of chronic hepatitis C.
    Asselah T; Boyer N; Ripault MP; Martinot M; Marcellin P
    Minerva Gastroenterol Dietol; 2007 Mar; 53(1):9-23. PubMed ID: 17415342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up.
    Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G
    J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does antiviral therapy prevent hepatocellular carcinoma?
    Kwon H; Lok AS
    Antivir Ther; 2011; 16(6):787-95. PubMed ID: 21900710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
    Shindo M; Ken A; Okuno T
    Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A small-sized hepatocellular carcinoma].
    Barbare JC
    Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B159-64. PubMed ID: 12843953
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hepatitis C].
    Moradpour D; Blum HE
    Ther Umsch; 2004 Aug; 61(8):493-8. PubMed ID: 15457965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [What therapy is meaningful in chronic hepatitis C and resection of hepatocellular carcinoma for recurrence prophylaxis?].
    Malfertheiner P
    Dtsch Med Wochenschr; 2002 Nov; 127(48):2580. PubMed ID: 12457331
    [No Abstract]   [Full Text] [Related]  

  • 40. [Highlights in gastroenterology 2006].
    Bauerfeind P; Müllhaupt B; Schöfl R; Rösch T; Schwizer W; Wirth HP; Kullak-Ublick GA; Fried M
    Praxis (Bern 1994); 2006 Nov; 95(46):1793-804. PubMed ID: 17136827
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.